Position in DHR
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$754,681
-$274,088 QoQ
Shares Held
3,962
-27.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#1,193
of 2,098 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 50%
Shared 0%
None 50%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Convergence Financial, LLC holds $3,110,070 across 2 Diagnostics & Research names. DHR ranks #2 (24.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
4,698 | $2,355,389 | |
| 2 | DHR |
Danaher Corp /De/
This page
|
3,962 | $754,681 |
All Filings in DHR
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $754,681 | 3,962 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $1,028,769 | 5,426 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $736,435 | 3,217 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $641,371 | 3,235 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $642,992 | 3,255 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $254,815 | 1,243 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $234,141 | 1,020 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $355,031 | 1,277 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $368,029 | 1,473 | Shares | Sole | 2024-10-23 | |
| No filing history on record for this holder in this stock. | ||||||